Trial Profile
Identification of Disease Progression Specific Biomarkers and Their Pharmacologic Modulation for Keratoconus.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Keratoconus
- Focus Biomarker; Therapeutic Use
- 24 Nov 2015 New trial record